SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

American Renal Associates Holdings, Inc. – IPO: ‘S-1/A’ on 9/29/15 – ‘EX-3.1.3’

On:  Tuesday, 9/29/15, at 8:54pm ET   ·   As of:  9/30/15   ·   Private-to-Public:  Document/Exhibit  –  Release Delayed   ·   Accession #:  1047469-15-7605   ·   File #:  333-206686

Previous ‘S-1’:  ‘S-1’ on 8/31/15   ·   Next:  ‘S-1/A’ on 11/10/15   ·   Latest:  ‘S-1/A’ on 4/20/16

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 9/30/15  American Renal Assocs Holdin… Inc S-1/A¶                27:11M                                    Merrill Corp/New/FA

Initial Public Offering (IPO):  Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   2.56M 
                (General Form)                                                   
27: CORRESP   ¶ Comment-Response or Other Letter to the SEC         HTML     49K 
 2: EX-3.1.1    Articles of Incorporation/Organization or By-Laws   HTML     27K 
 3: EX-3.1.2    Articles of Incorporation/Organization or By-Laws   HTML     16K 
 4: EX-3.1.3    Articles of Incorporation/Organization or By-Laws   HTML     15K 
 5: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     79K 
 6: EX-3.3      Articles of Incorporation/Organization or By-Laws   HTML     28K 
 7: EX-3.4      Articles of Incorporation/Organization or By-Laws   HTML    115K 
 8: EX-10.1     Material Contract                                   HTML   2.64M 
15: EX-10.11    Material Contract                                   HTML     22K 
16: EX-10.12    Material Contract                                   HTML     74K 
17: EX-10.13    Material Contract                                   HTML     70K 
18: EX-10.14    Material Contract                                   HTML     57K 
19: EX-10.15    Material Contract                                   HTML     70K 
20: EX-10.16    Material Contract                                   HTML     64K 
21: EX-10.18    Material Contract                                   HTML     43K 
22: EX-10.19    Material Contract                                   HTML     22K 
23: EX-10.20    Material Contract                                   HTML    178K 
24: EX-10.22    Material Contract                                   HTML    134K 
25: EX-10.25    Material Contract                                   HTML     83K 
 9: EX-10.3     Material Contract                                   HTML   1.26M 
10: EX-10.4     Material Contract                                   HTML    129K 
11: EX-10.5     Material Contract                                   HTML     27K 
12: EX-10.7     Material Contract                                   HTML    125K 
13: EX-10.8     Material Contract                                   HTML    129K 
14: EX-10.9     Material Contract                                   HTML     18K 
26: EX-23.2     Consent of Experts or Counsel                       HTML     11K 


‘EX-3.1.3’   —   Articles of Incorporation/Organization or By-Laws


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]




Exhibit 3.1.3

 

CERTIFICATE OF AMENDMENT
TO THE RESTATED
CERTIFICATE OF INCORPORATION OF
AMERICAN RENAL ASSOCIATES HOLDINGS, INC.

 

Adopted in accordance with the provisions
of Section 242 of the General Corporation
Law of the State of Delaware

 

The undersigned, being an authorized officer of American Renal Associates Holdings, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify as follows:

 

1.             The original Certificate of Incorporation of the Corporation is hereby amended by changing Article FOURTH thereof so that, as amended, Article FOURTH shall read in its entirety as follows:

 

“FOURTH: The total number of shares of all classes of stock that the Corporation shall have the authority to issue is 14,000,000 shares, which shall be divided into two classes as follows:

 

1.             13,000,000 shares of Common Stock, par value $0.01 per share (the “Common Stock”); and

 

2.             1,000,000 shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”).”

 

2.             The directors of the Corporation duly approved and adopted the foregoing amendment, declared such amendment to be advisable and referred such amendment to the stockholders of the Corporation for consideration thereof in accordance with the provisions of the DGCL by resolution of the directors of the Corporation on March 24, 2014, in accordance with the provisions of Section 242 of the DGCL.

 

3.             The foregoing amendment has been duly approved and adopted in accordance with the provisions of the DGCL by the written consent of a majority of the stockholders of the Corporation on March 24, 2014 in accordance with the provisions of Section 228 of the DGCL.

 



 

IN WITNESS WHEREOF, the undersigned has caused this Certificate to be signed this 24th day of March, 2014.

 

 

 

AMERICAN RENAL ASSOCIATES HOLDINGS, INC.

 

 

 

 

By:

/s/ Joseph A. Calucci

 

 

Name:

Joseph A. Carlucci

 

 

Title:

Chairman and CEO

 




Dates Referenced Herein

This ‘S-1/A’ Filing    Date    Other Filings
Filed as of:9/30/15None on these Dates
Filed on:9/29/15
3/24/14
 List all Filings 
Top
Filing Submission 0001047469-15-007605   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 6:47:21.1am ET